Inflammatory breast cancer biomarkers and biology

Int Rev Cell Mol Biol. 2024;384:63-76. doi: 10.1016/bs.ircmb.2023.11.002. Epub 2024 Feb 5.ABSTRACTInflammatory breast cancer (IBC) is a unique breast cancer with a highly virulent course and low 5- and 10-year survival rates. Even though it only accounts for 1-5% of breast cancers it is estimated to account for 10% of breast cancer deaths annually in the United States. The accuracy of diagnosis and classification of this unique cancer is a major concern within the medical community. Early molecular and biological studies incidentally included IBC samples with other conventional breast cancers and were not informative as to the unique nature of the disease. Subsequent molecular studies that focused specifically on IBC demonstrated that IBC has a unique biology different from other forms of breast cancer. Additionally, a handful of unique signature genes that are hallmarks of IBC have also been suggested. Further understanding of IBC biology can help with diagnosis and treatment of the disease. The current article reviews the history and highlights of IBC studies.PMID:38637100 | DOI:10.1016/bs.ircmb.2023.11.002
Source: Mol Biol Cell - Category: Molecular Biology Authors: Source Type: research